Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics - Test2 - elhamkhani - TriplyDB

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

http://www.wikidata.org/entity/Q24685475

about

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS A lentivirus-mediated genetic screen identifies dihydrofolate reductase (DHFR) as a modulator of beta-catenin/GSK3 signaling Akt is negatively regulated by the MULAN E3 ligase Ankrd2 is a modulator of NF-κB-mediated inflammatory responses during muscle differentiation Glycogen synthase kinase 3: a point of convergence for the host inflammatory response Wnt/beta-catenin signaling and small molecule inhibitors Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder Chronic over-nutrition and dysregulation of GSK3 in diseases Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair FBW7-mediated ubiquitination and degradation of KLF5 The Warburg effect revisited--lesson from the Sertoli cell Neuronal seipin knockout facilitates Aβ-induced neuroinflammation and neurotoxicity via reduction of PPARγ in hippocampus of mouse A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives Gsk3 Signalling and Redox Status in Bipolar Disorder: Evidence from Lithium Efficacy Anthocyanins from Vitis coignetiae Pulliat Inhibit Cancer Invasion and Epithelial-Mesenchymal Transition, but These Effects Can Be Attenuated by Tumor Necrosis Factor in Human Uterine Cervical Cancer HeLa Cells GSK3beta in ethanol neurotoxicity The role of GSK3beta in the development of the central nervous system Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system miRNA Alterations Modify Kinase Activation In The IGF-1 Pathway And Correlate With Colorectal Cancer Stage And Progression In Patients Multi-walled carbon nanotubes directly induce epithelial-mesenchymal transition in human bronchial epithelial cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis Pharmacological inhibition of glycogen synthase kinase 3 regulates T cell development in vitro Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis.Multisite phosphorylation disrupts arginine-glutamate salt bridge networks required for binding of cytoplasmic linker-associated protein 2 (CLASP2) to end-binding protein 1 (EB1).Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition.GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals Integrin-linked Kinase is Essential for Environmental Enrichment Enhanced Hippocampal Neurogenesis and Memory.Phosphorylation of SKAP by GSK3β ensures chromosome segregation by a temporal inhibition of Kif2b activity.Dynamic telomerase gene suppression via network effects of GSK3 inhibition GSK3beta and aging liver.Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells Cancer linked to Alzheimer disease but not vascular dementia.Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

P2860

Q21129334-6FCC026B-324D-4CE9-A9CB-6E02182C39D5 Q21142769-8E140637-1FE1-4F56-88F9-2788F111CD74 Q24307478-0C95FC4B-710B-411C-A980-6E676BE03B77 Q24321224-6AE438A4-875B-49F7-948C-ED3A73FA080B Q24597129-AB482473-FE45-4BA6-856F-E001420AA47B Q24597197-4499B66B-0EA9-4699-9099-F7F815D6784A Q24626017-E7DBB998-AFC9-4028-A9DD-3F00E24D21C3 Q26738964-49A7AB47-C98E-497F-8562-3DB9AD13003A Q26739711-77DE8BF6-9D46-4B40-8E77-ABAA2EB6D656 Q26768475-3A11A273-A7C2-47A7-8B90-8B6AAD438B1B Q26779424-56F96E03-6A5B-4466-AC03-F46EFB32D980 Q26783344-F5C3F142-16C8-4E37-8CC1-8AC65FE1A375 Q26865502-D8699DE8-C89E-4091-AB4B-3C0CEDC18B79 Q27010419-36E30051-F6D9-4233-A365-FD787D752BB0 Q27025749-55F0EF9A-365D-4E1B-8F2E-EF43DAEDF302 Q27303098-EFED0A7D-FD36-4051-9445-999A640CA550 Q28068709-0B9FAEF7-0F5C-447D-A170-735798B3D2FF Q28078551-DFF44423-522B-4213-AC32-86691B91AAEF Q28385365-EE8067F1-70C0-4075-8769-0803CFD27F2F Q28387181-21C6ED12-53DE-4005-A615-4069250BD10F Q28387853-371C9586-DBBA-4E56-B2ED-D857A65D54DF Q28389419-837112E0-4D53-40E4-A834-6593F2B3A3CB Q28392422-9B1CE965-BD3A-43F1-AE16-2D86B55F48F4 Q28395821-E67BA3B2-BC13-49C3-94DA-9CF3238929ED Q28472669-707EFB3D-904B-46B3-9615-09F3F0357311 Q28484135-867BD03C-0678-483D-A833-EC7D0BA9C793 Q28488493-09A623E6-DDCA-4374-8278-AE69B6C1C90B Q28509645-5282C454-728F-420A-8D20-EA72FC6AED20 Q28571669-1FA1A3D9-847A-4882-B980-3DF14FCA970F Q30485641-3A69400A-0C3E-4ACA-832E-502919443DCC Q30514537-E960732D-0E9A-43D5-8033-1406FDD37C91 Q30516491-8A926646-C224-4B21-9A2E-7D771BFA9AD7 Q30619452-FA1D0C94-A775-467C-83D2-356B38B63402 Q30655194-D49641E7-0B58-4D7A-B368-2231AFED160B Q30832109-5E56CDAE-C8E9-4810-B785-545B9D5B1F95 Q33489588-5E511916-3482-427D-A772-2DC00EAB48D5 Q33588732-79C8DABE-06BA-4A7D-A6B5-667897A585EB Q33597201-3A8B9388-8FFE-492B-A535-1F4AF6D1E138 Q33601291-5C167CF3-1E8D-453D-A57B-F4803D54E789 Q33636704-2762931C-0D17-4427-8410-B31638424E37

P2860

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

http://www.wikidata.org/entity/Q24685475

description

2007 nî lūn-bûn

@nan

2007 թուականին հրատարակուած գիտական յօդուած

@hyw

2007 թվականին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@ast

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@en

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@nl

type

label

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@ast

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@en

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@nl

prefLabel

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@ast

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@en

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@nl

P1433

Q24685475-18018864-64DA-412E-B2F9-DC74C795F302

P1476

Q24685475-A8F94629-AD19-453F-86D4-FCB1A517B431

P2093

Q24685475-1CEC7A55-CC50-4E38-B135-8C963AA98DCB

Q24685475-B6D5A119-FDBC-48CA-AC0B-2644E9AE058B

Q24685475-D6991CFC-059A-492A-9FF3-9562853C1C6A

P2860

Q24685475-019B3DBD-3736-435E-9AB3-4A793CDF131C

Q24685475-01A5AD12-F2F5-4200-B1DF-CC96EEFF8CE3

Q24685475-01B0F833-88DF-4EEF-A331-3A73BA66DA99

Q24685475-0359B1DE-71E5-4F24-B491-56BD9EE6F0A4

Q24685475-03A3B71E-27A1-4B70-AD83-C5D79AC33E00

Q24685475-0428D31C-A1A3-4008-92EC-AA5F22EB0115

Q24685475-04370BBF-DED0-4A7B-819F-740607A18830

Q24685475-0448B248-DF73-469D-AF2F-5D44A6E68D70

Q24685475-046BBDBF-62D9-4BC7-9222-A6A8B6890371

Q24685475-04C63296-F2A9-4953-AF48-70C214D34058

P2888

Q24685475-3E2C4DF2-143B-42E8-90D8-3C4EFDA0748B

P304

Q24685475-E82B022D-EB2B-4E17-88C2-B7179AA82C0B

P31

Q24685475-76BB147A-1B5E-4F22-98D7-9DFE6CD511FD

P3181

Q24685475-F23A8603-5B0E-47E0-8A13-8A128D23E483

P356

Q24685475-CAC582D0-B3DD-44CE-8D62-DB94939678E6

P407

Q24685475-958AAF57-AC86-4824-AA05-D174DD1EEF25

P433

Q24685475-1F08D1FD-84B6-48C2-B24D-E94DEBECD4B1

P478

Q24685475-864E005C-7B75-4FB0-8F19-BA028F5D70BE

P577

Q24685475-1E3564C4-440C-4668-9990-05CDA5C071CA

P5875

Q24685475-B61C32BA-7C7E-4D3F-AA2F-F6A5E23EC1A0

P6179

Q24685475-6FA7832F-FED3-4E9B-AED2-6FEC1CD641F9

P698

Q24685475-6E05E448-355A-45BE-9998-5335D778DDB2

P921

Q24685475-5371E324-3012-462F-8009-61A484F39155

P932

Q24685475-E1FFE50C-F042-4622-A249-1A1AE57701AF

P3181

P356

S11064-006-9128-5

P1433

Neurochemical Research

P1476

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

@en

P2093

Christopher J Yuskaitis

http://www.w3.org/2001/XMLSchema#string

Eléonore Beurel

http://www.w3.org/2001/XMLSchema#string

Richard S Jope

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin signalling and the regulation of glucose and lipid metabolism

Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules

Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition

Disruption of IRS-2 causes type 2 diabetes in mice

Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau

Inflammation, stress, and diabetes

Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage

Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions

A molecular mechanism for the effect of lithium on development

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

P2888

s11064-006-9128-5

P304

577-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

875440

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11064-006-9128-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

4-5

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6845147

http://www.w3.org/2001/XMLSchema#string

P6179

1043905982

http://www.w3.org/2001/XMLSchema#string

P698

16944320

http://www.w3.org/2001/XMLSchema#string

P921

P932

1970866

http://www.w3.org/2001/XMLSchema#string